Menu

Wilfried RAIMONDI

Beerse

En résumé

My dynamism, open-mindedness and will to learn helped me all along my studies which resulted in getting a B.Sc. followed by a M. Sc. in chemistry as proof of my strong practical and theoretical knowledge in organic chemistry.

These years were punctuated with internships relating to all the fields of organic chemistry.

My previous placements in both academic and industrial groups enabled me to develop qualities such as autonomy, leadership, communication and teamwork skills, but also to acquire a good chemical knowledge that I would like to extend.

After an international post-doctoral position at the Albert-Ludswig-Universitat in Freiburg, Germany, I am currently looking for any opportunity in the chemical industry.

Mes compétences :
Synthèse organique
Synthese multi-étapes
Catalyse organique
Catalyse métallique
Chimie hétérocyclique
Chimie des glucides
RMN 1H et 13C
FT-IR
HPLC
GC-MS
Chromatographie

Entreprises

  • Janssen Pharmaceutica - Chercheur R&D

    Beerse 2016 - 2017

  • Albert-Ludswigs-Universitat Freiburg - Chercheur post-doctoral

    2013 - 2015 This postdoctoral stay in the Breit group (Germany) was carried out in the field of organometallic chemistry, more especially in metallic catalysis.

    I developed a methodology allowing the enantioselective formation of tertiary and quaternary allylic C-N bonds via the rhodium-catalyzed redox-neutral coupling of tetrazoles with allenes.

    The reactivity of the allylic moiety was exploited and standard reaction conditions were used to derivatize the products (hydroboration, hydroformylation, etc).

    The allylated tetrazoles were also successfully engaged in a diastereoselective photochemical transformation to access 1,2-diazabicyclo[3.1.0]hex-2-enes.

    Most of this work was recently published in Chemical Communications.

    Chem. Commun., 2015, 51, 10861-10863 (DOI: 10.1039/C5CC04203H)

  • Aix-Marseille Université - Doctorant

    Marseille 2009 - 2012 My research work consisted in developing new organocatalyzed reactions involving the reactivity of nitroalkenes. The developed methodologies were then applied to the approach to the total synthesis of natural and complex biologically active compounds such as scandine.

    My work was published in 9 papers to date (pdf can be found below) and exposed through several national and European oral communications.

    I efficiently supervised several B. Sc. and M. Sc. trainees as well as students' practical classes, allowing me to develop strong leadership skills.

    Moreover, I was an active member of the associative board of the PhD students of Marseille, and also an elected representative of PhD and post-doctoral students at the "Institut des Sciences Moléculaires de Marseille" scientific board.

  • Roche Pharmaceuticals - Stagiaire

    2009 - 2009 I synthesized and coupled nicotinic acid and benzoic acid derivatives with a piperidinamine to get molecules that could be interesting in the treatment of schizophrenia.

    Piperidines were also built to study by NMR 1H the influence of the grafted substituents on the adopted conformation.

  • Colorado State University - Stagiaire

    Casablanca 2008 - 2008 I joined the Rovis group to develop and compare 2 different strategies involving a Rh-catalyzed enantioselective [2+2+2] cycloaddition to access lythrine, an alkaloid that may be useful in treating Addison’s disease and general nephrosis.

  • Arc'Antique - Stagiaire

    2007 - 2007 The project consisted in investigating and putting protecting agents on the surface of iron-based archaeological objects coming from the ocean floors in order to limit the manifestations of corrosion, and comparison of the efficiency of the engaged protecting agents. A protection that proved to be long-time efficient without altering the aesthetic quality was successfully developed.

  • Institut de Chimie Moléculaire et des Matériaux d'Orsay - Stagiaire

    2006 - 2006 I synthesized two monosaccharides, derived from D-glucose and N-acetylglucosamine, that served as precursors of “Octa-10”, an octasaccharide that could be efficient in the treatment of auto-immune diseases (Crohn’s disease, sclerosis).

Formations

  • ENSCCF (Clermont Ferrand)

    Clermont Ferrand 2008 - 2009 Diplôme d'Ingénieur Chimiste

    Option Chimie Organique Fine et Industrielle (COFI)

  • ENSCCF (Clermont Ferrand)

    Clermont Ferrand 2007 - 2008 Préparation du diplôme d'ingénieur chimiste
    Seconde année

  • ENSCCF (Clermont Ferrand)

    Clermont Ferrand 2006 - 2007 Préparation du diplôme d'ingénieur chimiste
    Première année

  • IUT Chimie

    Orsay 2004 - 2006 DUT Chimie

    Classé 2nd sur 100

Réseau

Annuaire des membres :